TL;DR
In a seafarer disability claim, the Supreme Court ruled that while a company-designated physician’s assessment is not absolute, it carries significant weight, especially when the seafarer fails to follow the proper procedure for challenging it. The Court emphasized that seafarers who disagree with the company doctor’s findings must initiate a third-party doctor consultation as stipulated in the POEA-SEC. Failing to do so, and instead immediately filing a complaint, undermines the contractual process and strengthens the presumption of validity of the company doctor’s assessment, unless clear bias or lack of scientific basis is proven.
Fair Seas and Second Opinions: Charting the Course for Seafarer Disability Assessments
When a seafarer suffers injury at sea, determining disability benefits can become a contentious voyage. This case, Magsaysay Mitsui OSK Marine, Inc. vs. Oliver G. Buenaventura, navigates the process of medical assessments in seafarer disability claims, specifically addressing the weight given to company-designated physicians’ findings and the seafarer’s right to a second opinion. At the heart of the dispute is the interpretation of the Philippine Overseas Employment Administration Standard Employment Contract (POEA-SEC) and the established protocols for resolving medical disagreements. The central legal question is: When a seafarer disputes a company doctor’s ‘fit-to-work’ assessment, what procedural steps must be taken, and what is the evidentiary weight of the company doctor’s opinion if these steps are not followed?
Oliver Buenaventura, an ordinary seaman, sustained a severe hand injury while working aboard a vessel. Upon repatriation, he was attended to by company-designated physicians who, after several months of treatment and rehabilitation, declared him fit to work. Buenaventura, still experiencing pain, sought independent medical opinions from two other doctors who deemed him unfit for sea duty. Instead of initiating the third-doctor referral process outlined in the POEA-SEC to resolve this conflict, Buenaventura directly filed a complaint for disability benefits. The Labor Arbiter (LA) and the National Labor Relations Commission (NLRC) sided with the company, upholding the company doctor’s fit-to-work assessment. However, the Court of Appeals (CA) reversed, finding Buenaventura entitled to permanent and total disability benefits, primarily because the company doctor’s final assessment came after the initial 120-day period from repatriation. This CA decision forms the basis of the Supreme Court review.
The Supreme Court, in reversing the CA, clarified the procedural and evidentiary aspects of seafarer disability claims. The Court affirmed that while the company-designated physician has the initial opportunity to assess the seafarer’s condition, their findings are not absolute. Seafarers have the right to seek a second opinion. The POEA-SEC explicitly provides a mechanism for resolving differing medical opinions: referral to a third, mutually agreed-upon doctor, whose decision shall be final and binding. Section 20(A) of the POEA-SEC is clear:
“[S]hould the seafarer’s appointed doctor disagree with the assessment [of the company-designated physician], a third doctor may be agreed upon by the employer and the seafarer and the latter’s decision shall be final and binding between the parties.”
Building on this principle, the Court emphasized that Buenaventura’s failure to initiate this third-doctor referral process was a critical procedural lapse. By immediately filing a complaint instead of seeking a third opinion, Buenaventura disregarded the contractual procedure established in the POEA-SEC. The Court cited precedent, noting that “the duty to secure the opinion of a third doctor belongs to the employee asking for disability benefits.” This obligation arises when there is a conflict in medical opinions, and it is the seafarer’s responsibility to bring this conflict to the employer’s attention and propose the third-doctor consultation.
Furthermore, the Supreme Court addressed the CA’s reliance on the lapse of the 120-day period. The Court clarified the interplay between the 120-day and 240-day periods for medical assessment. While the initial period is 120 days, it can be extended up to 240 days if further medical treatment is required and justified by the company-designated physician. In Buenaventura’s case, the Court found that the extension was justified as he underwent continuous therapy and rehabilitation, and the fit-to-work assessment was issued within the extended 240-day period. The Court referenced Elburg Shipmanagement Phils., Inc. v. Quiogue, which harmonized the jurisprudence on these periods, stating:
“If the treatment of 120 days is extended to 240 days, but still no medical assessment is given, the finding of permanent and total disability becomes conclusive.”
However, in this case, a fit-to-work assessment was issued within the 240-day timeframe, negating the automatic presumption of permanent disability based solely on the lapse of the initial 120 days. The Court underscored that the extent of disability is determined by the medical grading based on the incapacity to work, not solely by the number of days of treatment, though the prescribed periods for assessment must be observed.
In conclusion, the Supreme Court’s decision in Buenaventura reinforces the importance of procedural compliance in seafarer disability claims. It clarifies that while seafarers have the right to challenge company doctors’ assessments, they must follow the POEA-SEC’s third-doctor referral process. Failure to do so strengthens the evidentiary weight of the company-designated physician’s opinion, absent demonstrable bias or lack of medical basis. This ruling provides a clearer framework for navigating medical disputes in seafarer disability cases, emphasizing both the seafarer’s rights and the contractual procedures designed to resolve disagreements fairly and efficiently.
FAQs
| What was the key issue in this case? | The central issue was whether the seafarer was entitled to disability benefits despite a company-designated physician declaring him fit to work, and whether the seafarer properly challenged this assessment. |
| What is the role of the company-designated physician? | The company-designated physician has the first opportunity to assess a seafarer’s medical condition and issue a medical assessment, which initially informs the entitlement to disability benefits. |
| Can a seafarer challenge the company doctor’s assessment? | Yes, seafarers can challenge the company doctor’s assessment if they disagree with it by seeking a second opinion from a doctor of their choice. |
| What is the third-doctor referral process? | If there’s disagreement between the company doctor and the seafarer’s doctor, the POEA-SEC mandates referral to a third, mutually agreed-upon doctor, whose decision is final and binding. |
| What happens if the seafarer doesn’t follow the third-doctor process? | If the seafarer fails to initiate the third-doctor referral, the company-designated physician’s assessment is given more weight, unless clear bias or lack of scientific basis is proven. |
| What are the 120-day and 240-day periods? | The company doctor has 120 days to issue a final assessment, extendable to 240 days if justified by ongoing treatment. Failure to assess within 240 days can lead to automatic permanent disability. |
| Was the seafarer in this case awarded disability benefits? | No, the Supreme Court reversed the Court of Appeals’ decision and dismissed the seafarer’s claim for disability benefits, upholding the company-designated physician’s fit-to-work assessment due to procedural lapses. |
For inquiries regarding the application of this ruling to specific circumstances, please contact Atty. Gabriel Ablola through gaboogle.com or via email at connect@gaboogle.com.
Disclaimer: This analysis is provided for informational purposes only and does not constitute legal advice. For specific legal guidance tailored to your situation, please consult with a qualified attorney.
Source: Magsaysay Mitsui OSK Marine, Inc. vs. Buenaventura, G.R. No. 195878, January 10, 2018

Leave a Reply